Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/20/1991 | CN1014790B Process for preparing novel benzoxazol-and benzothiazolamine derivatives and their use |
11/20/1991 | CN1014789B Process for preparing replacable bridged heavy nitrogen bicycloalkyl carbostyril carboxylic acid |
11/20/1991 | CN1014787B Phenoxyacetic acid derivative and processes for preparing same |
11/20/1991 | CN1014774B Producing method of drug composition for dobutamine salts |
11/20/1991 | CA2042860A1 Bicyclic 1-aza-cycloalkanes |
11/19/1991 | WO1991017984A1 (3-alkylthio propyl)-3 benzothiazoline derivatives, preparation thereof and drugs containing said derivatives |
11/19/1991 | WO1991017747A1 Sustained/enhanced antipyretic response |
11/19/1991 | US5066828 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
11/19/1991 | US5066812 Chemical intermediates for bactericides |
11/19/1991 | US5066805 Catalytic hydrogenation of 2-amino-6-chloropurine |
11/19/1991 | US5066802 Process for preparing pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues |
11/19/1991 | US5066801 Preparation of sulfonic acid esters |
11/19/1991 | US5066800 Qunoline intermediates useful therein for synthesizing antibacterial compounds |
11/19/1991 | US5066798 Crystalline cephalosporin derivative |
11/19/1991 | US5066680 Novel substituted-acetamide compound and a process for the preparation thereof |
11/19/1991 | US5066679 Phenolic thioalkylamides as inhibitors of 5-lipoxygenase |
11/19/1991 | US5066678 Phenethandamine derivatives and pharmaceutical use thereof |
11/19/1991 | US5066677 Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain |
11/19/1991 | US5066676 Sulfonamido derivative inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them |
11/19/1991 | US5066674 Carbamate inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents |
11/19/1991 | US5066671 Ellagic acid derivatives as phospholipase A2 inhibitors |
11/19/1991 | US5066670 Macrolide derivatives with parasiticidal activity |
11/19/1991 | US5066669 Benzofuran derivatives |
11/19/1991 | US5066666 Aminoazole derivatives and their production and use |
11/19/1991 | US5066660 Indole derivatives |
11/19/1991 | US5066652 Antiulcer agents |
11/19/1991 | US5066651 Sulfonyl group attached to nitrogen, Alzheimer*s disease, antihypoxic, antiischemic, memory lapses |
11/19/1991 | US5066650 Method for suppressing the endocrine system |
11/19/1991 | US5066649 8,9-annelated-1,2,3,4-tetrahydro-β-carboline derivatives |
11/19/1991 | US5066647 Freeze dried, quick dissolving, improved shelf life |
11/19/1991 | US5066646 Antifungal Agents |
11/19/1991 | US5066645 Antitumor agents |
11/19/1991 | US5066495 Improving shelf life by mixing with excipient, reduced moisture content |
11/19/1991 | US5066493 Treatment Of Colon Tumors |
11/19/1991 | US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
11/19/1991 | US5066487 Antisudoral composition comprising dibasic aluminium salts of acylated amino acids |
11/19/1991 | US5066480 Treating pulmonary hypertension caused by protamine induced neutralization of heparin |
11/19/1991 | US5066436 Microencapsulating Bioactive Substances In Biocompatible Polymers |
11/19/1991 | US5066427 Eicosatriynoic acid esters and their application in pharmaceutical and cosmetic practice |
11/19/1991 | US5066274 Tetrapyrrole therapeutic agents |
11/19/1991 | US5065866 Storage phosphor cassette assembly |
11/19/1991 | CA2080692A1 Sustained/enhanced antipyretic response |
11/19/1991 | CA2074833A1 (alkylthio-3 propyl)-3 benzothiazoline derivatives, their preparation and drugs holding same |
11/19/1991 | CA2042875A1 Aminopiperidin, aminopyrrolidin and aminoperhydroazepin derivatives, their preparation process and pharmaceutical compositions containing them |
11/19/1991 | CA1292244C Hydroxamic acid derivatives and method of using same |
11/19/1991 | CA1292240C Triglyceride composition |
11/19/1991 | CA1292239C Cycloalkyl-substituted 4-aminophenyl halo derivatives and process for their preparation |
11/19/1991 | CA1292236C Process for preparing n-alkylated amino acids and esters thereof |
11/19/1991 | CA1292235C Derivatives of 5-pentylamino-5-oxopentanoic and 4- pentylamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin and a method for their preparation |
11/19/1991 | CA1292233C 5-(w-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno- (3,2-c)-pyridine derivatives |
11/19/1991 | CA1292232C 3-(piperidinyl)- and 3-(pyrrolidinyl)-lh-indazoles, a process for their preparation and their use as a medicament |
11/19/1991 | CA1292226C Indenothiazole derivative and process for preparing the same |
11/19/1991 | CA1292224C Ergoline esters |
11/19/1991 | CA1292223C Esters of dihydrolysergic acid and related compounds |
11/19/1991 | CA1292186C Rectally absorbable form of l-dopa |
11/19/1991 | CA1292185C Use of synthetic sulfated saccharides to enhance wound healing |
11/19/1991 | CA1292184C Treatment of systematic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
11/19/1991 | CA1292145C Nutritional fat suitable for enteral and parenteral products |
11/18/1991 | WO1991017752A1 Percutaneous preparation containing estradiol |
11/18/1991 | WO1991017749A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
11/18/1991 | CA2084208A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
11/18/1991 | CA2042795A1 Antiviral agents |
11/18/1991 | CA2042764A1 Use of substituted 1,2,4-triazinediones |
11/18/1991 | CA2042752A1 Novel application of 4-carbamoyl-1- b -d-ribofuranosyl imidazolium-5-olate |
11/18/1991 | CA2042737A1 .alpha.-oxopyrrolo[2,3-b]indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments |
11/18/1991 | CA2042638A1 4-alkylamino-6-(c3-5-hydrocarbyl)thieno [2,3-b]thiopyran-2-sulfonamide-7,7-dioxides |
11/18/1991 | CA2041846A1 Therapeutic agents |
11/18/1991 | CA2038899A1 Method for controlled dermal penetration and topical compositions useful therefor |
11/18/1991 | CA2017163A1 Thioproline derivatives |
11/17/1991 | WO1991018593A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders |
11/17/1991 | WO1991017989A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/17/1991 | CA2083040A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/17/1991 | CA2080818A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyerproliferative disorders |
11/17/1991 | CA2042458A1 Oligophosphates with an antiviral action |
11/17/1991 | CA2017037A1 Composition for treatment of progressive myopia |
11/16/1991 | WO1991017757A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
11/16/1991 | CA2064067A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
11/16/1991 | CA2042558A1 Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime, process of preparation and use in the preparation of medicines and pharmaceutical compositions having same |
11/15/1991 | WO1991017738A1 Color modified melanins and methods for their preparation and use |
11/15/1991 | CA2042463A1 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation |
11/15/1991 | CA2042443A1 Tricyclic compounds |
11/15/1991 | CA2042418A1 Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparasitic agents |
11/15/1991 | CA2016829A1 8,10-dideazatetrahydrofolic acid derivatives |
11/14/1991 | WO1991017504A1 Fault tolerant computer system |
11/14/1991 | WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | WO1991017165A1 Tetrahydrobenzothienopyridines, processes for their preparation and their use as pharmaceuticals |
11/14/1991 | WO1991017159A1 1,3-oxathiolane nucleoside analogues |
11/14/1991 | WO1991017156A1 Neuroprotective indolone and related derivatives |
11/14/1991 | WO1991017151A1 New pharmacologically active catechol derivatives |
11/14/1991 | WO1991017148A1 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders |
11/14/1991 | WO1991017146A1 Novel histamine h3-receptor agonist compounds for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation |
11/14/1991 | WO1991016920A1 Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs |
11/14/1991 | WO1991016908A1 Method and composition for treating psoriasis |
11/14/1991 | WO1991016904A1 Method for treating retroviral infections in mammals |
11/14/1991 | WO1991016899A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof |
11/14/1991 | WO1991016896A1 Pharmaceutical composition for use in treating pain |
11/14/1991 | WO1991016893A1 Pharmaceutical formulation |
11/14/1991 | WO1991016892A1 Styryl compounds which inhibit egf receptor protein tyrosine kinase |
11/14/1991 | WO1991016890A1 Benzylimidazole derivatives as anxiolytic and nootropic agents |
11/14/1991 | WO1991016886A1 Pharmaceutical composition containing ibuprofen and a prostaglandin |